Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs

Abstract

Importance of the problem: treatment efficiency improving in patients with multidrug-resistant destructive pulmonary tuberculosis (MDR). Aim. To study the complex treatment effectiveness in patients with destructive MDR with implementation of Glutamyl-cysteinyl-glycine disodium (GCGD) immunomodulator. Methods and results. On the basis of standard chemotherapy course main treatment effectiveness parameters have been estimated of 30 patients who were treated with implementation of GCGD on the basis of standard chemotherapy course and 30 patients who were treated with standard chemotherapy course alone. Conclusion. Complex treatment of patients with destructive MDR with implementation of GCGD immunomodulator on the basis of standard chemotherapy course for immunity state correction allows to increase effectiveness of treatment by 33,3%.

Keywords

• Immunomodulator
• Multidrug-Resistant Tuberculosis